as on January 28, 2026 at 9:37 pm IST
Day's High
3.51%
Upside
52 Week's Low
52 Week's High
10.53%
Downside
3514.04%
Upside
Check Kala Bio Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$16.2M
EPS (TTM)
-4.45
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-3.14
Industry PE ratio
-5.810789473684211
PEG Ratio
0EBITDA
-41.3M
Revenue (TTM)
-
Profit Margin
0.00%
Return On Equity TTM
-708.34%
Track how Kala Bio Inc P/E has moved over time to understand its valuation trends.
Kala Bio Inc in the last 5 years
Lowest (-3.99x)
March 31, 2021
Industry (-5.81x)
January 28, 2026
Today (-3.14x)
January 28, 2026
Highest (-0.26x)
December 31, 2022
Today’s Price to Earnings Ratio: -3.14x
Compare market cap, revenue, PE, and other key metrics of Kala Bio Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $16.2M | -99.84% | -3.14 | 0.00% | |
| BUY | $47.7B | 129.26% | 1246.03 | 1.36% | |
| BUY | $122.3B | 106.13% | 33.56 | 31.35% | |
| NA | $37.4B | NA | 662.33 | 1.38% | |
| BUY | $80.8B | 52.34% | 18.28 | 32.13% |
The Kala Bio Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Kala Bio Inc investment value today
Current value as on today
₹12,474
Returns
Returns from Kala Bio Inc Stock
Dollar Returns*
₹5,974 (+5.97%)
Based on 9 analysts
88.89%
Buy
11.11%
Hold
0.00%
Sell
Based on 9 analysts, 88.89% of analysts recommend a 'BUY' rating for Kala Bio Inc. Average target price of $1.5
Get share price movements and forecasts by analysts on Kala Bio Inc.
What analysts predicted
62%UPSIDE
Target Price
$1.5
Current Price
$0.57
Analyzed by
9 Analysts
Target
$1.50
Kala Bio Inc target price $1.5, a slight upside of 62% compared to current price of $0.57. According to 9 analysts rating.
Investment in Kala Bio Inc Shares on INDmoney has dropped by -86.34% over the past 30 days, indicating reduced transactional activity.
Time period: to
Search interest for Kala Bio Inc Stock has decreased by -83% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 29 September
Mon, 09:30 PM
-Kala Bio halts KPI-012 development after trial fails to meet primary endpoints, plans workforce reduction and strategic evaluations.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Profit Spike
![]()
Netprofit is up for the last 2 quarters, -11.15M → -7.56M (in $), with an average increase of 47.5% per quarter
Revenue Rich
![]()
Revenue is up for the last 2 quarters, 70.0K → 254.0K (in $), with an average increase of 72.4% per quarter
Against Peers
![]()
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 29.4% return, outperforming this stock by 126.4%
Against Peers
![]()
In the last 1 year, Beone Medicines Ltd has given 48.3% return, outperforming this stock by 141.5%
Price Dip
![]()
In the last 6 months, KALA stock has moved down by -92.5%
| Organisation | Kala Bio Inc |
| Headquarters | 1167 Massachusetts Avenue, Arlington, MA, United States, 02476 |
| Industry | Health Technology |
| CEO | Mr. David Elliot Lazar |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Ms. Jill S. Steier | Executive Director of Investor Relations & Corporate Communications |
Mr. Darius Kharabi J.D., M.B.A. | Chief Business Officer |
Dr. Francis S. Mah M.D. | Chief Medical Advisor |
Mr. Josiah Craver | Senior VP & Corporate Controller |
Mr. Vincent Kosewski | Senior VP of Manufacturing & Supply Chain Management |
Ms. Mary Reumuth CPA | Treasurer & Secretary |
Dr. R. Kim Brazzell Ph.D. | Head of R&D and Chief Medical Officer |
Mr. Todd Bazemore | Principal Executive Officer & Director |
Mr. David Elliot Lazar | CEO, CFO, President, COO & Chair of the Board |
Dr. Justin Hanes Ph.D. | Founder & Chair of the Scientific Advisory Board |
Kala Bio Inc share price today is $0.57 as on . Kala Bio Inc share today touched a day high of $0.59 and a low of $0.57.
Kala Bio Inc share touched a 52 week high of $20.6 on and a 52 week low of $0.51 on . Kala Bio Inc stock price today i.e. is trending at $0.57,which is 97.23% down from its 52 week high and 11.76% up from its 52 week low.
Kala Bio Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Kala Bio Inc (KALA) shares with as little as ₹91.762 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹917.62 in Kala Bio Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Kala Bio Inc share’s latest price of $0.57 as on January 28, 2026 at 9:37 pm IST, you will get 17.5439 shares of Kala Bio Inc. Learn more about
fractional shares .
Kala Bio Inc stock has given -99.84% share price returns and 25.73% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?